Pacira Financial Statements From 2010 to 2026
| PCRX Stock | USD 23.53 2.49 9.57% |
Check Pacira BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences Valuation or Volatility modules.
Check out the analysis of Pacira BioSciences Correlation against competitors. Pacira BioSciences Company Return On Equity Analysis
Pacira BioSciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pacira BioSciences Return On Equity | 0.029 |
Most of Pacira BioSciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pacira BioSciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Pacira BioSciences has a Return On Equity of 0.029. This is 100.12% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on equity for all United States stocks is 109.35% lower than that of the firm.
Pacira BioSciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pacira BioSciences's current stock value. Our valuation model uses many indicators to compare Pacira BioSciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pacira BioSciences competition to find correlations between indicators driving Pacira BioSciences's intrinsic value. More Info.Pacira BioSciences is regarded second in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about 1.00 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pacira BioSciences' earnings, one of the primary drivers of an investment's value.About Pacira BioSciences Financial Statements
Pacira BioSciences investors use historical fundamental indicators, such as Pacira BioSciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences. Please read more on our technical analysis and fundamental analysis pages.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida. Pacira Pharm operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 697 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.